Thus, we speculated that a 24% increase in LCAT activity in our FH model with ApoC3 deficiency was sufficient to elevate ApoA1 levels but could not influence plasma cholesterol levels, including HDL-C. This evidence concerns the gene LCAT and familial hyperaldosteronism.